Diseases Archives - Page 11 of 43 - Pharma Journalist

FDA and CE mark approvals granted to Orthofix’s PhysioStim Bone Growth Stimulators

Compugen licenses Selexis’ Cell line-Based Protein Expression Platform

FDA clearance granted to Premier Biotech’s Oral Fluid Drug Testing Device, OralTox

PCMA conveys response to Scott Gottlieb’s comments on Biosimilars

FDA Commissioner Scott Gottlieb vows to commit to market review of Essure

Zydus partners Medicure to launch its NDA product, ZYPITAMAG

Perrigo receives final approval from FDA for OTC equivalent of Mucinex DM

Veloxis submits sNDA to FDA seeking new indication for ENVARSUS XR

Biohaven enrolls first patient in Phase 3 Clinical Trial to assess Rimegepant Zydis ODT to treat Migraine

Apexigen and Pediatric Brain Tumor Consortium collaborate to evaluate APX005M in Brain tumor children